Business Context and Reporting Period
This Form 8-K Current Report was filed by Quantum-Si Incorporated on June 10, 2022. The filing reports a corporate governance event: the appointment of a new director to the Board of Directors.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on the appointment of a board member.
Material Changes
The material change reported is the expansion of the Board of Directors from six to seven members. Vikram Bajaj, Ph.D., was appointed effective June 15, 2022, to serve until the next annual meeting of stockholders. Dr. Bajaj was also appointed to the Compensation Committee.
Management Commentary and Risks
The Board determined that Dr. Bajaj is an independent director under Nasdaq listing rules. His qualifications include extensive leadership in the life sciences industry, including roles as Managing Director at Foresite Capital Management, CEO of Foresite Labs, and former Chief Scientific Officer at GRAIL, Inc. and Verily Life Sciences LLC. Dr. Bajaj will receive standard nonemployee director compensation pro-rated for the year and will enter into a standard indemnification agreement. No unusual items or specific risks were disclosed in this report.
Key Facts for Investors
- New Director: Vikram Bajaj, Ph.D., joins the Board effective June 15, 2022.
- Board Size: Increased from six to seven members.
- Committee Assignment: Dr. Bajaj serves on the Compensation Committee.
- Independence: The Board has affirmed Dr. Bajaj's status as an independent director.
- Related Party Status: Dr. Bajaj is associated with Foresite Capital Management, a beneficial owner of more than 5% of the Company's common stock.